Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ACTRN12625001438448) titled 'Empagliflozin in cystic fibrosis related diabetes' on Dec. 18, 2025.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Efficacy
Primary Sponsor: Western Sydney Local Health District
Condition:
cystic fibrosis
cystic fibrosis related diabetes
cystic fibrosis
cystic fibrosis related diabetes
Respiratory - Other respiratory disorders / diseases
Metabolic and Endocrine - Diabetes
Human Genetics and Inherited Disorders - Cystic fibrosis
Intervention:
Randomised controlled trial of empagli...